Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov 10:29:101749.
doi: 10.1016/j.ajoc.2022.101749. eCollection 2023 Mar.

Hydrus Microstent implantation with OMNI Surgical System Ab interno canaloplasty for the management of open-angle glaucoma in phakic patients refractory to medical therapy

Affiliations
Case Reports

Hydrus Microstent implantation with OMNI Surgical System Ab interno canaloplasty for the management of open-angle glaucoma in phakic patients refractory to medical therapy

Jack Creagmile et al. Am J Ophthalmol Case Rep. .

Abstract

Purpose: To report a series of 8 phakic eyes of 8 patients with open angle glaucoma with uncontrolled intraocular pressure on maximum tolerable medical therapy receiving Hydrus Microstent implants combined with concomitant OMNI Surgical System ab interno canaloplasty.

Observations: 8 phakic eyes underwent Hydrus Microstent implantation with OMNI Surgical System ab interno canaloplasty. 2 patients underwent concurrent Kahook Dual Blade goniotomy and 1 patient underwent a concurrent micropulse transscleral cyclophotocoagulation. 6 out of 8 eyes achieved successful intraocular pressure reduction. Only 1 achieved success without the need for additional medical therapy. 1 required Neodymium-doped yttrium aluminum garnet laser to clear iris obstruction of the Hydrus inlet and 1 required selective laser trabeculoplasty for additional intraocular pressure lowering. 2 out of 8 eyes required subsequent incisional glaucoma surgery for unacceptable intraocular pressure levels despite maximum tolerable medical therapy.

Conclusions and importance: The Hydrus Microstent combined with OMNI Surgical System ab interno canaloplasty can safely and successfully reduce intraocular pressure in phakic patients with open-angle glaucoma with uncontrolled intraocular pressure on maximum tolerable medical therapy with a low complication rate and rapid visual recovery.

Keywords: Glaucoma; Hydrus microstent; MIGS; Minimally invasive glaucoma surgery; OMNI Surgical system; Phakic.

PubMed Disclaimer

Conflict of interest statement

The following authors have no financial disclosures: J.C.; W.K.; C.S.

References

    1. Gulati V., Fan S., Hays C.L., Samuelson T.W., Ahmed I.I.K., Toris C.B. A novel 8-mm Schlemm's canal scaffold reduces outflow resistance in a human anterior segment perfusion model. Investig Ophthalmol Vis Sci. 2013;54(3):1698–1704. - PubMed
    1. Shareef S., Fea A., Ahmed I.I.K. The hydrus micro-stent. Surgical Innovations in Glaucoma. 2013:171–174.
    1. Samuelson T.W., Chang D.F., Marquis R., et al. A Schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON study. Ophthalmology. 2019;126(1):29–37. - PubMed
    1. Ahmed I.I.K., Fea A., Au L., et al. A prospective randomized trial comparing hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma: the COMPARE study. Ophthalmology. 2020;127(1):52–61. - PubMed
    1. Vold S.D., Williamson B.K., Hirsch L., et al. Canaloplasty and trabeculotomy with the OMNI system in pseudophakic patients with open-angle glaucoma: the ROMEO study. Ophthalmology Glaucoma. 2021;4(2):173–181. - PubMed

Publication types